Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Low-dose topical alpha-terthienyl may be a safer option for treating skin conditions with light therapy.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

A new, efficient method was developed to synthesize a specific compound and its derivatives.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Scientists found out how a medicinal plant makes compounds with health benefits.

A rigid compound with a common structural motif was successfully synthesized.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Chlorinated compounds like TCDD can cause skin issues and chloracne by affecting cell behavior.

The new biodegradable nanocarriers safely and effectively deliver drugs into the skin.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

New steroids were effective in blocking male hormone receptors in hamster prostates.